Theophylline/Salbutamol

茶碱沙丁胺醇

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTheophylline/Salbutamol
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionAdenosine receptor antagonistsBeta-2 adrenergic receptor agonists
TargetsAdenosine receptorBeta-2 adrenergic receptor
Therapy Area/IndicationsAsthmaBronchitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsYes TheophyllineSalbutamol sulfate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsAsthmaBronchitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A